Rapid progress with induced pluripotent stem cells is bringing scientists closer to understanding their strengths and weaknesses as embryonic stem cell stand-ins.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Takahashi, K. & Yamanaka, S. Cell 126, 663–676 (2006).
Yu, J. et al. Science 318, 1917–1920 (2007).
Hockemeyer, D. et al. Cell Stem Cell 3, 346–353 (2008).
Yu, J. et al. Science 324, 797–801 (2009).
Zhou, H. et al. Cell Stem Cell 4, 381–384 (2009).
Lin, T. et al. Nat. Methods 6, 805–808 (2009).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Eisenstein, M. IPSCs: One cell to rule them all?. Nat Methods 7, 81–85 (2010). https://doi.org/10.1038/nmeth0110-81
Issue date:
DOI: https://doi.org/10.1038/nmeth0110-81
This article is cited by
-
Musculoskeletal Tissue Regeneration: the Role of the Stem Cells
Regenerative Engineering and Translational Medicine (2017)
-
Stem cells and regenerative medicine
Stem Cell Research & Therapy (2012)
